Positive results in trials of Alzheimer’s treatment

In latest trials, the NeuroAD cranial device from Israel’s Neuronix (see here) slowed the progression of the disease in 85% of patients suffering mild Alzheimer’s.  The treatment is now being used commercially in the UK (London, Berkshire, Chester and Manchester).


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *